Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DEVELAGE

Financiado

Cerrado

Pathways common to brain development and ageing defining strategies for prevent...

Pathways common to brain development and ageing defining strategies for preventive therapy and diagnostics The increasing number of elderly people will have a major impact on the prevalence of age-related diseases, which will pose major challenges to keep health systems in Europe sustainable. Current knowledge is insufficient to identi... ver más

31/12/2014

MEDIZINISCHE UNIVE...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

MEDIZINISCHE UNIVERSITAET WIEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 9 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-12-31 No tenemos la información de la convocatoria

0% 77% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

9 Participantes

MEDIZINISCHE UNIVERSITAET WI...

0.00€ | Lider

UM2

N.D. | Participante

Academisch Medisch Centrum A...

N.D. | Participante

FUNDACIO INSTITUT D?INVESTIG...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PSI2017-84290-R PREVENCION Y TRATAMIENTO DEL DECLIVE COGNITIVO ASOCIADO AL E... 70K€ Cerrado

PID2021-126715OB-I00 IMPLICACIONES DE LA PROTEINA PRECURSORA AMILOIDE (APP): NEUR... 236K€ Cerrado

PID2019-106772RB-I00 ESTUDIO LONGITUDINAL Y MULTIDISCIPLINAR ORIENTADO A LA DETER... 111K€ Cerrado

EAGER Elucidating the effects of ageing on the nucleoporin directe... 1M€ Cerrado

ADPROGRES Alzheimer disease progression Molecular studies of Abeta am... 75K€ Cerrado

SAF2016-80419-R REGULACION DE LA MULTIPOTENCIALIDAD DE CELULAS MADRE NEURALE... 157K€ Cerrado

Líder del proyecto

MEDIZINISCHE UNIVERSITAET WIEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The increasing number of elderly people will have a major impact on the prevalence of age-related diseases, which will pose major challenges to keep health systems in Europe sustainable. Current knowledge is insufficient to identify the transition of normal brain ageing into Alzheimer`s Disease (AD)-like brain damage. Elucidation of the genes and pathways contributing to the earliest stages of AD pathology and associated neurodegeneration should be instrumental to allow intervention when the condition is still reversible. The aim of the DEVELAGE project is to characterise shared molecular pathways between early developmental processes in the brain and brain ageing. Our concept is based on the hypothesis that disorders of neural development contribute to age-related neurodegeneration, that developmentally essential proteins might have a role in neurodegeneration, and that neurodegeneration-related proteins and genes are important during the development of the brain. The DEVELAGE approach is unique in that it is brain tissue-based, derived from neuropathological diagnosis with detailed molecular analysis of the spectrum of developmental and ageing changes in the very same brain samples used for a comprehensive array of investigations in humans as well as in experimental models at genetic, epigenetic, transcription and protein levels. DEVELAGE contributes to the understanding of biological variation by examining relevant number of cases with different phases of ageing and neurodegeneration as well as developing brains with or without developmental disorders. Pathways examined in humans will be validated in animal models, including a non-human primate, and vice versa. The combination of human samples and animal models susceptible to experimental manipulation will promote the translation of clinically relevant data into experimentally testable predictions and promotes the exploitation of therapeutically relevant targets to reverse or halt disease progresssion.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores